These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 26006087)

  • 61. Immunization with DNA through the skin.
    Peachman KK; Rao M; Alving CR
    Methods; 2003 Nov; 31(3):232-42. PubMed ID: 14511956
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Opportunities and challenges in delivering influenza vaccine by microneedle patch.
    Jacoby E; Jarrahian C; Hull HF; Zehrung D
    Vaccine; 2015 Sep; 33(37):4699-704. PubMed ID: 25842218
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Induction of cytotoxic T-lymphocytes by electroporation-enhanced needle-free skin immunization.
    Zhao YL; Murthy SN; Manjili MH; Guan LJ; Sen A; Hui SW
    Vaccine; 2006 Feb; 24(9):1282-90. PubMed ID: 16225969
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Skin targeted DNA vaccine delivery using electroporation in rabbits. I: efficacy.
    Medi BM; Hoselton S; Marepalli RB; Singh J
    Int J Pharm; 2005 Apr; 294(1-2):53-63. PubMed ID: 15814230
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Colloidal carrier systems for transcutaneous immunization.
    Gupta PN; Vyas SP
    Curr Drug Targets; 2011 Apr; 12(4):579-97. PubMed ID: 21226670
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Dendritic cells of mucosa and skin: "recruited for vaccination"].
    Le Borgne M; Dubois B; Kaiserlian D
    Med Sci (Paris); 2007 Oct; 23(10):819-25. PubMed ID: 17937889
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Microneedles: a valuable physical enhancer to increase transdermal drug delivery.
    Escobar-Chávez JJ; Bonilla-Martínez D; Villegas-González MA; Molina-Trinidad E; Casas-Alancaster N; Revilla-Vázquez AL
    J Clin Pharmacol; 2011 Jul; 51(7):964-77. PubMed ID: 21148047
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Solid-in-oil nanodispersions for transdermal drug delivery systems.
    Kitaoka M; Wakabayashi R; Kamiya N; Goto M
    Biotechnol J; 2016 Nov; 11(11):1375-1385. PubMed ID: 27529824
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Development of transcutaneous vaccine formulations for the infectious disease countermeasure].
    Matsuo K; Okada N; Nakagawa S
    Nihon Rinsho; 2011 Sep; 69(9):1561-6. PubMed ID: 21922753
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Transcutaneous immunization with Intercell's vaccine delivery system.
    Seid RC; Look JL; Ruiz C; Frolov V; Flyer D; Schafer J; Ellingsworth L
    Vaccine; 2012 Jun; 30(29):4349-54. PubMed ID: 22682290
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Transcutaneous immunization and immunostimulant strategies.
    Glenn GM; Kenney RT; Hammond SA; Ellingsworth LR
    Immunol Allergy Clin North Am; 2003 Nov; 23(4):787-813. PubMed ID: 14753392
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system.
    Laurent PE; Bonnet S; Alchas P; Regolini P; Mikszta JA; Pettis R; Harvey NG
    Vaccine; 2007 Dec; 25(52):8833-42. PubMed ID: 18023942
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Enhancing vaccine effectiveness with delivery technology.
    Beitelshees M; Li Y; Pfeifer BA
    Curr Opin Biotechnol; 2016 Dec; 42():24-29. PubMed ID: 26954947
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Microneedle-Mediated Vaccination: Innovation and Translation.
    Sheng T; Luo B; Zhang W; Ge X; Yu J; Zhang Y; Gu Z
    Adv Drug Deliv Rev; 2021 Dec; 179():113919. PubMed ID: 34375682
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical performance and safety of adapters for intradermal delivery with conventional and autodisable syringes.
    Tsals I; Jarrahian C; Snyder FE; Saganic L; Saxon E; Zehrung D; Zimmerman G; Papania M; Klaff L
    Vaccine; 2015 Sep; 33(37):4705-11. PubMed ID: 25964169
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Delivery Strategies for Skin: Comparison of Nanoliter Jets, Needles and Topical Solutions.
    Cu K; Bansal R; Mitragotri S; Fernandez Rivas D
    Ann Biomed Eng; 2020 Jul; 48(7):2028-2039. PubMed ID: 31617044
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nanoparticles for transcutaneous vaccination.
    Hansen S; Lehr CM
    Microb Biotechnol; 2012 Mar; 5(2):156-67. PubMed ID: 21854553
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Single-injection vaccines: Progress, challenges, and opportunities.
    McHugh KJ; Guarecuco R; Langer R; Jaklenec A
    J Control Release; 2015 Dec; 219():596-609. PubMed ID: 26254198
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Particle based vaccine formulations for transcutaneous immunization.
    Mittal A; Raber AS; Lehr CM; Hansen S
    Hum Vaccin Immunother; 2013 Sep; 9(9):1950-5. PubMed ID: 23778884
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Novel ablative laser mediated transdermal immunization for microparticulate measles vaccine.
    Joshi D; Gala RP; Uddin MN; D'Souza MJ
    Int J Pharm; 2021 Sep; 606():120882. PubMed ID: 34298102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.